IPIX — Innovation Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Innovation Pharmaceuticals provides development update on Brilacidin
Brief: Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial
Brief: Innovation Pharmaceuticals says files for mixed shelf offering of up to $75 mln
Special Report: Stronger 'superbugs,' and no new drugs to fight them
Brief: Cellceutix releases pharmacokinetics data from phase 2 trial of Prurisol
Brief: Cellceutix to submit special protocol assessment request to FDA for Phase 3 clinical study of antibiotic Brilacidin for absssi
Brief: Cellceutix to request meeting with FDA for phase 2 ovarian cancer study
Brief: Cellceutix loss per share $0.02
Brief: Criteo S.A. sees IPO of 7.2 million ads priced between $27.00 and $29.00